Alembic Pharmaceuticals Ltd
Company Profile
Business description
Alembic Pharmaceuticals Ltd is a vertically integrated pharmaceutical company engaged in the pharmaceuticals business. Its products are broadly classified into Active Pharmaceutical Ingredients (APIs), Formulations and International Generics, serving a large international and national customer base across various geographies. Its manufacturing infrastructure is equipped to serve the full spectrum of complex and specialty pharmaceutical segments spanning drug delivery formats, oncology, injectables, ophthalmics and dermatology. Customers include pharmaceutical companies engaged in the formulation business, patients, healthcare facilities and pharmaceutical distributors.
Contact
Alembic Road
VadodaraGJ390 003
INDT: +91 2656637000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
20,149
Stocks News & Analysis
stocks
Anthropic’s leaked financials reflect fast growth, but not a $2 trillion valuation
stocks
The 10 best US companies to invest in now
stocks
Surge in combat drones drives upgrade for ASX share
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,859.20 | 4.50 | 0.05% |
| CAC 40 | 7,834.10 | 63.09 | -0.80% |
| DAX 40 | 25,254.21 | 23.01 | 0.09% |
| Dow JONES (US) | 51,267.90 | 90.94 | 0.18% |
| FTSE 100 | 10,497.94 | 35.99 | 0.34% |
| HKSE | 24,040.34 | 68.05 | 0.28% |
| NASDAQ | 27,477.31 | 286.45 | 1.05% |
| Nikkei 225 | 69,946.86 | 1,637.40 | 2.40% |
| NZX 50 Index | 13,701.63 | 2.61 | 0.02% |
| S&P 500 | 7,773.95 | 51.23 | 0.66% |
| S&P/ASX 200 | 8,686.40 | 4.30 | 0.05% |
| SSE Composite Index | 3,842.19 | 11.74 | 0.31% |